15 小时
GlobalData on MSNLineage begins study of OPC1 delivering device for spinal cord injury treatmentFailed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.3cY8rBmp.js ...
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...
Danés, principal investigator of the Cancer and Stem Cell Biology Lab at the Champalimaud Foundation, in Lisbon, has shown ...
Researchers have developed a 3D-printed |brain-like environment| where neurons grow similarly to a real brain.
This valuable study presents a mouse gastruloid model that can be used to generate hematopoietic progenitors as well as leukemic cells. However, in its current form, the manuscript is inadequate ...
Understanding how cells transform into specialized types during human development is a central challenge in biology. This ...
Lineage Cell Therapeutics (LCTX) announced that the Company has initiated the DOSED clinical study. The DOSED study will evaluate the safety ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果